Tao Yin
Union Hospital(CN)Nanchang University(CN)Kaohsiung Medical University(TW)Chinese Academy of Sciences(CN)Shanghai Library(CN)Kaohsiung Medical University Chung-Ho Memorial Hospital(TW)China University of Geosciences (Beijing)(CN)Shenyang Anorectal Hospital(CN)Shanghai Institute of Materia Medica(CN)Hainan General Hospital(CN)Chinese Academy of Agricultural Sciences(CN)Institute of Crop Sciences(CN)China Construction Eighth Engineering Division (China)(CN)Hubei Cancer Hospital(CN)Union Hospital(CN)University of Chinese Academy of Sciences(CN)Huazhong University of Science and Technology(CN)Chengdu University of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Hepatocellular Carcinoma Treatment and Prognosis, RNA modifications and cancer
Most-Cited Works
- → Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study(2021)1,051 cited
- → Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial(2023)431 cited
- → Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice(2016)236 cited
- → Up‐regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine‐resistant pancreatic cancer cells(2017)160 cited
- → Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade(2016)151 cited
- → Establishment of Clonal Colony-Forming Assay for Propagation of Pancreatic Cancer Cells With Stem Cell Properties